44 filings
6-K
MOR
Morphosys AG
3 Dec 19
Announces His Departure
8:42am
6-K
MOR
Morphosys AG
20 Nov 19
Current report (foreign)
6:11am
6-K
MOR
Morphosys AG
19 Nov 19
Current report (foreign)
6:14am
6-K
MOR
Morphosys AG
12 Nov 19
Results for Bimagrumab in Obesity and Type 2 Diabetes presented by MorphoSys’s Partner
6:26am
6-K
MOR
Morphosys AG
7 Nov 19
Current report (foreign)
1:56pm
6-K
db6aywf49m13
7 Nov 19
Current report (foreign)
6:18am
6-K
n0u zqyy7egr
7 Nov 19
MorphoSys to Present Data on Tafasitamab at ASH 2019 Meeting
6:18am
6-K
vwo4y
30 Oct 19
Third Quarter Interim Statement
10:03am
6-K
vr6n2g41
30 Oct 19
Current report (foreign)
6:13am
6-K
f8qd3yac35ird e7j1q
29 Oct 19
Current report (foreign)
8:56am
6-K
m2di3
15 Oct 19
Current report (foreign)
8:00am
6-K
qlxjed 955qbxv4ig
11 Oct 19
Current report (foreign)
6:13am
6-K
eamjrxw8ex3j40l peq
17 Sep 19
Current report (foreign)
6:13am
6-K
be1hh bc2u
9 Aug 19
Current report (foreign)
6:18am
6-K
5knohhozssjxvhlx7rem
8 Aug 19
Half-Year Report January – June 2019
6:38am
6-K
wmc0xylo3xc c2w9q
8 Aug 19
Current report (foreign)
6:32am
6-K
qzzqp 6m2e
8 Aug 19
MorphoSys Announces Intention to Submit Marketing Authorization
6:27am
6-K
8mcg3m
10 Jul 19
Current report (foreign)
6:26am
6-K
clr3 dyju
10 Jul 19
MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology
6:21am
6-K
gomsw aky0c
3 Jul 19
Current report (foreign)
11:11am